1. Home
  2. BIO vs EVR Comparison

BIO vs EVR Comparison

Compare BIO & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$299.95

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$342.18

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
EVR
Founded
1952
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Investment Managers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
11.7B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BIO
EVR
Price
$299.95
$342.18
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$358.50
$332.22
AVG Volume (30 Days)
170.4K
349.0K
Earning Date
10-29-2025
02-04-2026
Dividend Yield
N/A
0.98%
EPS Growth
N/A
61.11
EPS
N/A
12.55
Revenue
$2,557,500,000.00
$3,542,875,000.00
Revenue This Year
$1.77
$25.39
Revenue Next Year
$2.30
$16.43
P/E Ratio
N/A
$27.28
Revenue Growth
N/A
27.03
52 Week Low
$211.43
$148.63
52 Week High
$373.69
$364.42

Technical Indicators

Market Signals
Indicator
BIO
EVR
Relative Strength Index (RSI) 39.06 63.45
Support Level $298.02 $330.45
Resistance Level $307.78 $343.09
Average True Range (ATR) 8.35 10.61
MACD -2.13 0.72
Stochastic Oscillator 16.30 77.71

Price Performance

Historical Comparison
BIO
EVR

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

Share on Social Networks: